NeuroXtherapeutics SA
CH-MF-000051571 · Switzerland · Lausanne
NeuroXtherapeutics SA is registered in the European database on medical devices as a manufacturer, with 5 devices declared. It is also registered as a device establishment with the U.S. FDA.
What this manufacturer declares
| Class IIa | 5 |
|---|
Among these devices, 5 are declared active.
Authorised representative in the Union: MDSS GmbH.
Devices declared under this manufacturer
- IZAR
- MindMotion Companion
- MindMotion GO
- MindMotion ToapRun
- MindPod Dolphin
Catalogue references include CMP-01, DLP-01, MMG-01, MMIZ-01, TPR-01.
European nomenclature codes declared: Z12069092, Z12069080.
United States market access
| FDA establishment register | Registered with FDA |
|---|---|
| Matched entry | NeuroXtherapeutics SA (CH) · FDA 3013517146 |
| Devices in EUDAMED | 5 |
| Country of registration | Switzerland |
Device-level evidence
| Devices with a numeric GTIN | 5 |
|---|---|
| Found in the U.S. device database | 3 |
| Share | 60.0 % |
Canadian market access
| Health Canada licence listing | Not found in the Canadian register |
|---|
⚠️ Canada lists no Class I devices at all — what that excludes.
North American profile: United States only. NeuroXtherapeutics SA is registered in the United States but was not found in the Canadian register.
Notified body certificates
| Certificate | Status | Expiry |
|---|---|---|
40366 | supplemented | 2029-12-19 |